Clinical and anthropometric profile of patients with diagnosis of non-alcoholic hepatic steatosis
Abstract
Introduction: Non-alcoholic hepatic steatosis is defined by the intrahepatic fat accumulation, and can be classified into three levels determined according to the proportion of fat-containing liver cells. The disease seems to be more prevalent in individuals with altered anthropometric profile, especially with high abdominal circumference and obesity, and some biochemical parameters. Objective: To describe the clinical and anthropometric profile of patients with non - alcoholic hepatic steatosis. Materials and Methods: This was a cross-sectional study, whose data were demographic (age and gender), clinical (biochemical exams and diagnosis of pathologies) and anthropometric (weight, height and circumference of the abdomen). The descriptive analysis of the variables was performed through the SPSS 20.0 program and the results are expressed in absolute and relative numbers. Results: Data were collected from 10 patients of both genders between the ages of 35 and 66 years. Most of them presented a diagnosis of grade II non-alcoholic hepatic steatosis, and the means obtained in the biochemical tests were higher in these subjects. As to the anthropometric profile, all participants were overweight, 70% of them were classified as obese, and all participants had altered abdomen circumference. Conclusion: In the studied population, the prevalence of male gender, obesity, high abdomen circumference and grade II of liver disease were found as profile.
References
-Amarapurkar, D.N.; Patel, N.D. Clinical spectrum and natural history of nonalcoholic steatohepatitis with normal alanine aminotransferase values. Tropical Gastroenterology. Vol. 25. Num. 3. 2004. p. 130–134.
-Bacon, B.R.; Farakvash, M.J.; Janney, C.G.; Neuschwander-Tetri, B.A. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology. Vol. 107. Num. 4. 1994. p. 1103-1109.
-Bilchik, A.J.; Poston, G.; Curley, S.A.; Strasberg, S.; Saltz, L.; Adam, R.; Nordlinger, B.; Rougier, P.; Rosen, L.S. Neodjuvant chemotherapy for metastic colon câncer: a cautionary note. Journal of Clinical Oncology. Vol. 23. Num. 36. 2005. p. 9073-9078.
-Brandt, R.L.; Audard, V.; Sartorelli, P. Severe hepatic sinusoidal obstruction associated with oxalipplatin-based chemotherapy in patients with metastatic colorectal câncer. Annals of Oncology. Vol. 15. Num. 3. 2004. p. 460-466.
-Brasil. IBGE. Instituto Brasileiro de Geografia e Estatística. Pesquisa de Orçamentos Familiares (POF) 2008, 2009 -Antropometria e estado nutricional de crianças, adolescentes e adultos no Brasil; 2010 [citado: 16 agosto 2015]. Disponível em: http://www.ibge.gov.br/home/presidnecia/noticias/imprens/ppts/0000000108.pdf
-Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde. Vigitel Brasil 2016: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico: estimativas sobre frequência e distribuição sociodemográfica de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2016. Brasília: Ministério da Saúde, 2017. 160p.: il.
-Chen, Z.W.; Chen, L.Y.; Dai, H.L.; Chen, J.H.; Fang, L.Z. Relação entre os níveis de alanina aminotransferase e síndrome metabólica na doença hepática gordurosa não alcoólica. Journal of Zhejiang University Science B. Vol. 9. Num. 8. 2008. p. 616-622.
-Cruz, J.F.; Cruz, M.A.F.; Macena, L.B.; Coutinho, P.M.; França, A.; Oliveira, C.C.C.; Lima, S.O. Relação entre homa-ir e aminotransferases com o grau de esteatose hepática pela ultrassonografia. Anais da 16ª Semana de Pesquisa da Universidade Tiradentes. Ciência e Tecnologia Para um País Sem Fronteiras. Num. 16. 2014. Disponível em https://eventos.set.edu.br/index.php/sempesq/issue/view/1.
-Duarte, A.C.G. Avaliação Nutricional Aspectos Clínicos e Laboratoriais. Atheneu. 2007. p.17-193.
-Dyson, J.K.; Anstee, M.Q.; Mcpherson, S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontiline Gastroenterology. Vol. 5. Num. 3. 2014. p. 211-218.
-Eifler, R.V. O papel da ultrassonografia na medida da gordura subcutânea e visceral e sua correlação com a esteatose hepática. Radiologia Brasileira. Vol. 46. Num. 5. 2013. p. 273-278. Disponível em: http://dx.doi.org/10.1590/S0100-39842013000500002.
-Frith, J.; Day, C.P.; Henderson, E.; Burt, A.D.; Newton, J.L. Non-alcoholic fatty liver disease in older people. Gerontology. Vol. 55. Num. 6. 2009. p. 607-613.
-Hashimoto, E.; Yatsuji, S.; Kaneda, H.; Yoshioka, Y.; Taniai, M.; Tokushige, K.; Shiratori, K. The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease. Hepatology Research. Vol. 33. Num. 2. 2005. p. 72-76.
-Hsiao, T.J.; Chen, J.C.; Wang, J.D. Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients. Vol. 28. Num. 1. 2004. p. 167-172.
-International diabetes federation. IDF. The IDF consensus worldwide definition of the metabolic syndrome.2005 [citado em 13 agosto 2014]. Disponível em: http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf.
-Ilias, E.J. Tratamento cirúrgico da esteatohepatite não-alcoólica e da doença gordurosa do fígado não-alcoólica. Revista da Associação Médica Brasileira. Vol. 56. Num. 4. 2010. p. 381-381.
-Lee, J.Y.; Kim, K.M.; Lee, S.G.; Yu, E.; Lim, Y.S.; Lee, H.C.; Chung, Y.H.; Lee, Y.S.; Suh, D.J. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. Journal of Hepatology. Vol. 47. Num. 2. 2007. p. 239-244.
-Leon, L.B.; Becker, S.C.C.; Petry, R.C.; Wink, E.F.; Lantz, F.; Tovo, C.V. Doença hepática gordurosa não alcoólica em pacientes com índice de massa corporal normal: etiologia e fatores de risco associados em um hospital terciário. Revista da AMRIGS. Porto Alegre. Vol. 58. Num. 1. 2014. p. 44-48.
-Liu, Y.Z.; Chen, J.K.; Zhang, Y.; Wang, X.; Qu, S.; Jiang, C.L. Chronic stress induces steatohepatitis while decreases visceral fat mass in mice. BMC Gastroenterology. Vol. 106. Num. 14. 2014. p. 1-8.
-Matteoni, C.A.; Younossi, Z.M.; Gramlich, T.; Boparai, N.; Liu, Y.C.; McCullough, A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Vol. 116, Num. 6. 1999. p. 1413-1419.
-Milić, S.; Štimac, D. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment. Digestive Diseases. Vol. 30. Num. 2. 2012. p. 158-162.
-Moore, J.B. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. The Proceedings of the Nutrition Society. Vol. 69. Num. 2. 2010. p. 211-220.
-Nascimbeni, F.; Pais, R.; Bellentani, S.; Day, C.P.; Ratziu, V.; Loria, P.; Lonardo, A. From NAFLD in clinical practice to answers from guidelines. Journal of Hepatology.; Vol. 59. Num. 4. 2013. p. 859-871.
-Ong, J.P.; Elariny, H.; Collantes, R.; Younoszai, A.; Chandhoke, V.; Reines, H.D. Goodman, Z.; Younossi, Z.M. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.Obes Surg. Vol. 15. Num. 3. 2005. p. 310-315.
-Patt, C.H.; Yoo, H.Y.; Dibadj, K.; Flynn, J.; Thuluvath, P. J. Prevalence of transaminase abnormalities in asymptomatic, healthy subjects participating in executive health-screening program. Digestive Disease and Sciences. Vol. 48. Num. 4. 2003. p. 797-801.
-Ratziu, V.; Bellentani, S.; Cortez-Pinto, H.; Day, C.; Marchesini, G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. Journal of Hepatology. Vol. 53. Num. 2. 2010. 372-384.
-Schild, B.Z.; Santos, L.N.; Alves, M.K. Doença hepática gordurosa não alcoólica e sua relação com a síndrome metabólica no pré-operatório de pacientes submetidos à cirurgia bariátrica. Revista da Associação Médica Brasileira. Vol. 59. Num. 2. 2013. p. 155-160.
-Sorrentino, P.; Tarantino, G.; Conca, P.; Perrella, A.; Terracciano, M.L.; Vecchione, R. Gargiulo, G.; Gennarelli, N.; Lobello, R. Silent non-alcoholic fatty liver disease a clinical–histological study. Journal of Hepatology. Vol. 41. Num. 5. 2004. p. 751-757.
-Stranges, S.; Dorn, J.M.; Muti, P.; Freudenheim, J.L.; Farinaro, E.; Russell, M.; Nochajski, T.H.; Trevisan, M. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Vol. 39. Num. 3. 2004. p. 754-763.
-Vernon, G.; Baranova, A.; Younossi, Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Alimentary Pharmacology & Therapeutics. Vol. 34. 2011. p. 274-285.
-Whalley, S.; Puvanachandra, P.; Desai, A.; Kennedy, H. Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs.Vol. 7. Num. 2. 2007. p. 119-124.
-WHO: World Health Organization. Obesity: preventing and managing the global epidemic. Report of a World Health Organization Consultation. Geneva: World Health Organization, 2000. p. 256. WHO Obesity Technical Report Serie n. 284.
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with work simultaneously licensed under the Creative Commons Attribution License BY-NC which allows the sharing of the work with acknowledgment of the authorship of the work and initial publication in this journal.
- Authors are authorized to enter into additional contracts separately for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to post and distribute their work online (eg, in institutional repositories or on their personal page) at any point before or during the editorial process, as this can bring about productive change as well as increase impact and impact. citation of published work (See The Effect of Free Access).
